You are here: Home Categories Bladder Cancer
Beyond the Abstract - A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group, by Maurizio Brausi

Beyond the Abstract - A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group, by Maurizio Brausi

Published on 18 June 2012
  • Print

BERKELEY, CA (UroToday.com) - Bacillus Calmette-Guérin (BCG) is currently regarded as the most effective intravesical treatment available for the management of non-muscle invasive bladder cancer (NMIBC).

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.
Tags:
Comments (0)
Only registered users can write comments!

Bladder Cancer